Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04900675
Other study ID # 878649
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date October 31, 2024

Study information

Verified date September 2023
Source Universitaet Innsbruck
Contact Markus Canazei, PhD
Phone 0043-512-507
Email markus.canazei@uibk.ac.at
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Increased stress levels are a significant problem for many students and represent a risk factor for impaired mental and physical health as well as academic performance. Stress levels are particularly high during the preparation phase for major exams. There is good evidence that light therapy is an effective treatment option to improve mood in affective disorders. The present study aims at investigating the psychophysiological effects of a 3-week morning bright light exposure in reducing stress and stress-related problems in students preparing for major exams.


Description:

Increased students' stress represents a significant risk factor for impaired mental and physical health as well as academic performance. The World Mental Health Survey (WHO) reports a 12-month prevalence of mental illness of 20.3% among students, with anxiety disorders (14.7%), affective disorders (9.9%), and substance abuse (6.7%) being particularly prominent. Moreover, six out of 10 students suffer from impaired sleep quality. Offering an effective treatment for stress-related symptoms in students is a challenge. In situations of intense stress, conventional methods such as relaxation and mindfulness-based programs often fail because of poor prior practice. Only a few students apply cognitive behavioral interventions. Although medication might decrease stress symptoms within days, the side effects of drugs cannot be ignored. Therefore, there is a need for effective and efficient treatment of acute stress symptoms in students. Bright light therapy is an effective treatment for several mental disorders, e.g. affective disorders and sleep disorders. There is some evidence, that exposure to bright light may even reduce stress in patients with burnout symptoms. Thus, exposure to bright light may be a promising new option to reduce academic stress and improve mood and sleep parameters. In the present study, a large-area desk lamp, which emits diffuse light and is controllable in its luminance and correlated color temperature is used. Study participants are randomly assigned to one of three study arms: (i) exposure to polychromatic light of 5,000 lux and 5,300 Kelvin, (ii) exposure to polychromatic light of 50 lux and 2,200 Kelvin, or (iii) no light intervention. Data collection takes place in winter periods.


Recruitment information / eligibility

Status Recruiting
Enrollment 125
Est. completion date October 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - students from the faculty of medicine, pharmacy, and law - major exam at least 5 weeks ahead - possession of smartphone and data plan Exclusion Criteria: - major depressive disorder (PHQ-9): Score > 4 - suicidal ideation (BDI, Item i): Rating > 1 - seasonal affective disorder (PIDS-A): Score > 11 - taking medication which increases photo-sensitivity - taking medication to increase cognitive performance - starting or changing pharmacotherapy for affective disorders and anxiety disorders within the last two weeks - changing of all kinds of medication within the last two weeks - headache (PHQ-D, Item f): Rating "severly impaired" - increased light sensitivity: Item "Wearing sunglasses outside on sunny days" is answered with 'often' or 'very often' - currently undergoing psychotherapeutic treatment - the presence of an eye disease for which light therapy is contraindicated

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Bright light intervention
Exposure with 5,000 lux at eye level for one hour and a Correlated Color Temperature of 5,300 Kelvin every morning for three weeks.
Reddish placebo light
Exposure with 50 lux at eye level for one hour and a Correlated Color Temperature of 2,200 Kelvin every morning for three weeks.

Locations

Country Name City State
Austria University of Innsbruck Innsbruck Tyrol

Sponsors (2)

Lead Sponsor Collaborator
Universitaet Innsbruck Bartenbach GmbH

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Other resilience Resilience Scale (RS-11); scale: RS-11 sum score; range: 11 - 77; higher RS-11 sum score means more perceived resilience Change from baseline RS-11 sum score at the end of week 3
Other stress coping Coping Inventory for Stressful Situations (CISS) - 24 items; three-dimensional CISS scale: (a) task-oriented coping; (b) emotion-oriented coping, and (c) avoidance-oriented coping; range for each dimension: 8 - 40; higher score in each dimension means higher preference for particular stress coping style Change from baseline multidimensional CISS scale at the end of week 3
Other learning strategies Learning Strategies of University Students (LIST-K) - 36 items; multidimensional LIST-K scale: 13 subscales; range for each dimension: 3 - 15; higher score in each dimension means higher preference for particular learning strategy Change from baseline multidimensional LIST-K scale at the end of week 3
Other psychological distress Brief Symptom Inventory (BSI-18); scale: BSI-18 sum score; range: 18 - 90; higher BSI-18 sum score means higher psychological distress Change from baseline BSI-18 overall score at the end of week 3
Other somatic symptoms The somatic symptom scale (SSS-8); scale: SSS-8 sum score; range: 0 - 32; higher SSS-8 sum score means higher somatic complaints Change from baseline SSS-8 sum score at the end of week 3
Other satisfaction with light intervention - short-term 2 items: (a) recommendation of light intervention to a friend and (b) follow-up usage of light intervention for own purposes; scale: binary score ('yes', 'no'); range: 0 - 1; higher binary scores indicate recommendation and follow-up usage of the light intervention day 5
Other satisfaction with light intervention - long-term 2 items: (a) recommendation of light intervention to a friend and (b) follow-up usage of light intervention for own purposes; scale: binary score ('yes', 'no'); range: 0 - 1; higher binary scores indicate recommendation and follow-up usage of the light intervention day 15
Other daily mood state Positive and Negative Affect Schedule (PANAS); two-dimensional PANAS scale: sum score for positive and negative mood state; range for each dimension: 10 - 50; higher PANAS scores mean higher positive and negative mood state, respectively changes from before the light intervention of the two-dimensional PANAS scale at the end of light intervention at each weekday during the light intervention period up to 3 weeks
Other weekly social rhythms The Social Rhythm Metric (SRM) measures the regularity in the occurance of 17 daily events; scale: SRM score; range: 0 - 7; higher SRM scores mean more regular occurance of daily events changes in SRM scores in week 1, week 2, and week 3
Other anxiety state State-Trait Anxiety Inventory (STAI - form Y) - 20 state items; scale: STAI-state sum score; range: 20 - 80; higher scores mean a higher subjective current anxiety level changes from before the light intervention STAI-state sum score at the end of light intervention in week 1, week 2, and week 3
Other cognitive performance The Number Letter Task (NLT) measures task switching performance; scale: number of correct answers; range: integer greater than or equal to 0; higher NLT scores means a better task switching performance changes from before the light intervention NLT number of correct answers at the end of light intervention in week 1, week 2, and week 3
Other exam anxiety German Test Anxiety Inventory (PAF); four-dimensional PAF scale: (a) excitement, (b) concern, (c) interference, and (d) lack of confidence; range for each dimension: 5 - 20; higher scale means higher test anxiety in the corresponding dimension changes of multidimensional PAF scale at week 1, week 2, and week 3
Primary subjective stress level - baseline/post Perceived Stress Scale (PSS-10); scale: PSS-10 sum score; range:0 - 40; higher scores mean a higher subjective stress level Change from baseline PSS-10 sum score at the end of week 3
Primary subjective stress level - baseline/post Perceived Stress Questionnaire (PSQ-20); scale: PSQ-20 sum score; range: 20 - 80; higher scores mean a higher subjective stress level Change from baseline PSQ-20 sum score at the end of week 3
Primary subjective stress level - on weekdays Perceived Stress Questionnaire (PSQ-20); scale: PSQ-20 sum score; range: 20 - 80; higher scores mean a higher subjective stress level Change of daily PSQ-20 sum score at each weekday during the light intervention period up to 3 weeks
Secondary anxiety State-Trait Anxiety Inventory (STAI - form Y) - 20 trait items; scale: STAI-trait sum score; range: 20 - 80; higher scores mean a higher subjective anxiety level Change from baseline STAI-trait sum score at the end of week 3
Secondary mood Center for Epidemiologic Studies Depression Scale (CES--D); scale: CES-D sum score; range: 0 - 60; higher scores mean a higher subjective depression level Change from baseline CES-D sum score at the end of week 3
Secondary sleep quality Pittsburgh Sleep Quality Index (PSQI); scale: global PSQI score; range: 0 - 21; higher scores mean a lower subjective sleep quality Change from baseline global PSQI score at the end of week 3
Secondary sleep quality - total sleep time Wrist actimetry to measure daily total sleep time (TST); scale: sleep duration; range: >0 (minutes); higher TST means longer sleep period Change of TST at each night during the light intervention period up to 3 weeks
Secondary sleep quality - sleep onset latency Wrist actimetry to measure daily sleep onset latency (SOL); scale: duration to fall asleep; range: >0 (minutes); higher SOL means longer period to fall asleep change of SOL at each night during the light intervention period up to 3 weeks
Secondary sleep quality - wake after sleep onset Wrist actimetry to measure daily wake after sleep onset (WASO); scale: duration of being awake during sleep period; range: greater than or equal to 0 (minutes); higher WASO means longer wake periods after sleep onset change of WASO at each night during the light intervention period up to 3 weeks
Secondary sleep quality - sleep efficiency Wrist actimetry to measure daily sleep efficiency (SE); scale: percentage; range: 0 - 100; higher SE means a higher undisturbed sleep change of SE at each night during the light intervention period up to 3 weeks
Secondary circadian rest/activity rhythm - interdaily stability Circadian rest-activity cycle parameter interdaily stability (IS) derived from weekly wrist actimetry data; scale: real number; range: 0 -1; higher IS means a higher stability in daily rest-activity cycles change of IV at each of the three light intervention weeks up to 3 weeks
Secondary circadian rest/activity rhythm - intradaily variability Circadian rest-activity cycle parameter intradaily variability (IV) derived from averaged wrist actimetry data over a period of 1 week; scale: real number; range: 0 - 2; higher IV means a higher variability in 24-h rest-activity cycle change of IS at each of the three light intervention weeks up to 3 weeks
Secondary physiological stress reaction cortisol level measured from hair sample; scale: real number (pg/mg); range: >0; higher hair cortisol level means higher physiological stress Change from baseline hair cortisol level at the end of week 3
Secondary adverse effects - short-term astenopic complaints measured with 12 items; scale: sum score; range: 10 - 60; higher sum score means more astenopic complaints day 5
Secondary adverse effects - long-term astenopic complaints scale measured with 12 items: sum score; range: 10 - 60; higher sum score means more astenopic complaints day 15
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Completed NCT02629016 - Stress Reduction: A Pilot Study With Adolescents N/A
Completed NCT02541240 - Effects of an Intervention to Enhance Resilience in Physical Therapy Students N/A
Completed NCT01406028 - Does Emotional Support Decrease In Vitro Fertilization Stress? N/A
Completed NCT00121160 - Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response Phase 1
Completed NCT02621775 - Effectiveness of Two Stress Management Programs in Adaptation Disorder With Anxiety (ADA) N/A
Recruiting NCT04474418 - Psychometric Characterization of Patients With Cardiac Arrhythmias
Completed NCT03310112 - Mindfulness Training in U.S. Army Cohorts N/A
Terminated NCT03893617 - Brief Stresses Experimental Study Phase 1
Active, not recruiting NCT05542498 - Promoting Stress Management and Engagement in Introductory Physics Courses With Mindfulness and Relaxation N/A
Completed NCT02394899 - Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease N/A
Terminated NCT00962273 - The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak N/A
Completed NCT00451126 - Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSST N/A
Completed NCT06051500 - Psychological and Physiological Effects of Different Objects of Breath Meditation N/A
Completed NCT02801045 - Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient N/A
Completed NCT03308344 - Mindfulness Training in Military Spouses N/A
Recruiting NCT06029348 - Cerebrovascular Health and Resilience in Midlife N/A
Completed NCT05869006 - The Effect of Designed SIA Instrument Supported Interpersonal Relations-Based Group Practice on Psychological Well-Being and Creativity N/A
Completed NCT04484649 - Sleeping Healthy/Living Healthy Development N/A